NCT02271919View on ClinicalTrials.gov

Varenicline and Combined NRT for Smoking Cessation

PHASE4CompletedINTERVENTIONAL
Enrollment

631

Participants

Timeline

Start Date

May 14, 2015

Primary Completion Date

May 21, 2025

Study Completion Date

May 21, 2025

Conditions
Cigarette SmokerTobacco Use Disorder
Interventions
DRUG

Nicotine Lozenge

Given PO

DRUG

Nicotine Patch

Given via patch

OTHER

Placebo

Given PO or via patch

OTHER

Tobacco Cessation Counseling

Receive behavioral smoking cessation counseling

DRUG

Varenicline

Given PO

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02271919 - Varenicline and Combined NRT for Smoking Cessation | Biotech Hunter | Biotech Hunter